Substance,Type of TRV,TRV Value,Study Details,"Threshold/
Non-threshold
Endpoint",TRV Derivation Method,"Critical
Effect(s)","Carcinogenicity
Classification",Source
Nickel sulfate,Inhalation TC,"2.0E-05
mg/m3","Study Type: chronic
Species: male and female F344/N rats
and B6C3F1 mice
Mode of Administration: inhalation
(whole body exposure chambers)
Exposure Regime: rats: 0, 0.12, 0.25,
or 0.5 mg nickel sulfate hexahydrate/m3
(equivalent to 0, 0.03, 0.06, or
0.11 mg nickel/m3); mice: 0, 0.25, 0.5,
or 1 mg nickel sulfate hexahydrate/m3
(equivalent to 0, 0.06, 0.11, or
0.22 mg nickel/m3); about 6 hours/day,
5 days/week
Duration: 104 weeks
Uncertainty Factors: 1000 (10 for
intraspecies variability, 10 for interspecies
variability, and 10 for use of a LOAEL)",LOAEL = 0.06 mg/m3,"LOAEL adjusted for
continuous exposure
LOAEL = 0.011 mg/m3
adj
Intermediate TC =
LOAEL /UF =
adj
1.1E-05 mg/m3
Value of 0.02 µg/m3 was
recommended as the
European air quality
standard based on soluble
nickel compounds
constituting <50% of total
nickel compounds
in ambient air","Respiratory tract
toxicity
(lung inflammation
[chronic active
inflammation,
macrophage and
lymphoid
hyperplasia,
alveolar
proteinosis,
fibrosis, lung
lesions, and
atrophy of the
olfactory
epithelium])","CEPA and IARC:
see nickel, mixture
of oxidic, sulfidic
and soluble
inorganic nickel
compounds
US EPA IRIS:
not assessed","CCME, 2015
(based on ECB,
2008 and CSTEE,
2001, derived
from NTP 1996)"
"Nickel, mixture of
oxidic, sulfidic and
soluble inorganic
nickel compounds",Inhalation UR,"1.3E+00
(mg/m3)–¹","Study Type: epidemiological
(occupational)
Species: humans
Mode of Exposure: inhalation
Exposure Concentrations: N/A
Duration: > 6 months
Uncertainty Factors: N/A","TC (5% tumourigenic
05
concentration) =
0.04 mg/m3","Inhalation UR =
0.05/TC
05
where 0.05 = 5% extra
cancer risk","Cancer
(lung, nasal,
kidney, prostrate,
buccal cavity)","CEPA:
classified as Group I
carcinogenic
to humans
(EC and HC, 1994e)
IARC: Group 1
classified as
carcinogenic
to humans
(IARC, 2012a)
US EPA: see
individual nickel
substances","EC and HC,
1994e, and
HC 1996
(based on
Doll et al., 1990)"
"Nickel, metallic","Inhalation TC
(provisional)","1.8E-05
mg/m3","Study Type: subchronic
Species: rabbits
Mode of Administration: inhalation
Exposure Regime: 0, 0.13 mg/m³
metallic nickel dust, 6 hours/day,
5 days/week
Duration: 4 and 8 months
Uncertainty Factors: 1000 (10 for
intraspecies variability, 10 for
interspecies variability, and 10 for
database deficiencies and a less
than chronic study)",LOAEL = 0.13 mg/m3,"LOAEL (rounded to
0.1 mg/m3) adjusted for
continuous exposure
LOAEL = 0.018 mg/m3
adj
TC = LOAEL /UF
adj","Respiratory
tract toxicity
(morphological
and biological
effects on
alveolar cells)","CEPA: Group VI
unclassifiable with
respect to
carcinogenicity
to humans
(EC and HC, 1994e)
IARC: Group 2B
possibly
carcinogenic
to humans
(IARC, 1990)
US EPA IRIS:
not classified","EC and HC,
1994e and
HC, 1996
(based on
Johansson et al.,
1983)"
